Physician profile
Xiaofei Wang
NPI 1841518313
$3,516.85
in general payments reported to CMS, 2019-2025
17 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2021: $13.23 · 2022: $98.29 · 2023: $504 · 2024: $309 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,749 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,749.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,540.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi US Services INC. | $1,540.00 | 2025 | |
| Alcon Vision LLC | $820.38 | 2019-2025 | Hydrus Microstent, Rocklatan, Simbrinza |
| Sun Pharmaceutical Industries INC. | $296.08 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $184.03 | 2025 | Vyzulta, Miebo, Xiidra |
| Harrow Eye, LLC | $146.43 | 2023-2025 | Vevye, Iheezo |
| Sirtex Medical INC | $134.48 | 2023 | Sir-Spheres Microspheres |
| Abbvie INC. | $69.26 | 2022-2025 | Alphagan P, Lumigan |
| Tarsus Pharmaceuticals, INC. | $52.73 | 2025 | Xdemvy |
| Amgen INC. | $47.99 | 2025 | Tepezza |
| Sight Sciences, INC. | $45.30 | 2024-2025 | Omni Surgical System |
| Dompe US, INC. | $35.85 | 2021-2022 | |
| Oyster Point Pharma, INC. | $28.79 | 2024 | Tyrvaya, Ryzumvi |
| Glaukos Corporation | $27.34 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Ocular Therapeutix, INC. | $25.91 | 2022 | |
| Rxsight INC | $22.39 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $22.07 | 2023 | |
| Abb Con-Cise Optical Group LLC | $17.82 | 2025 | Spectacle Lenses |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaofei Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.